This suggests that ITGA1 could potentially serve as a valuable biomarker for assessing cardiac function in individuals with type 2 diabetes and for distinguishing those at a higher risk of developing HFpEF. The gene discussed is ITGA1; the disease is type 2 diabetes mellitus.